Home›Compare›MangoRx vs Musely

MangoRx vs Musely: Which Is Better?

Head-to-head comparison of MangoRx and Musely based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Musely scores higher overall in our independent evaluation (67.9/100 vs 58/100), leading on trust & safety, value, experience, product range, reputation.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
68
Musely
Good

Telederm compounding platform selling doctor-prescribed topicals for pigmentation, aging, and hair loss alongside a growing menopause/longevity line.

Visit Musely

Score Breakdown

DimensionMangoRxMusely
Overall Score58/10067.9/100 ✓
Trust & Safety30%55/10065/100 ✓
Value25%62/10070/100 ✓
Experience20%58/10068/100 ✓
Product Range15%66/10072/100 ✓
Reputation10%45/10065/100 ✓

At a Glance

Founded20212011
HeadquartersDallas, TXSanta Clara County, CA
Publicly tradedYes (MGRX)No
Treatment categories53
Treatments listed53
Starting price$50/mo$50/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxMusely
Hair Loss$50–$80
Grow (compounded hair-loss formula)
$50–$100
Hair Topical Solution

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Musely

+Strong Trustpilot rating (4.1/5 across ~2,300 reviews) relative to compounding-derm peers
+Broad and unusually varied catalog spanning pigmentation, anti-aging, hair loss, and menopause care
+Fast shipping and quick support response times are consistently cited
−Exact pricing per product isn't published; site only gives a broad $50-100/month range
−Subscription renewal system is described by patients as rigid and hard to adjust
−Nearly identical bottle labeling across different formulas has caused reordering confusion
Read the full Musely review →

MangoRx vs Musely — FAQ

Is MangoRx better than Musely?

▾

Musely scores higher overall in our independent evaluation (67.9/100 vs 58/100), leading on trust & safety, value, experience, product range, reputation.

Is MangoRx or Musely cheaper?

▾

Their entry prices are similar — both start around $50/mo. Real cost depends on the specific treatment: compare the pricing tables on each review, since inclusions like consults, labs, and shipping differ.

What do MangoRx and Musely both offer?

▾

Both platforms treat Hair Loss. MangoRx covers 5 treatment categories total and Musely covers 3.

Still deciding?

MangoRx alternativesMusely alternativesTake the Match Quiz